A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants.
Clinical trial NCT05329623 · COMPLETED
Trial details
- NCT number
- NCT05329623
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-03
- Primary completion
- 2024-04-07
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.